S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Man kills 4 relatives in Queens knife rampage, injures 2 officers before he's fatally shot by police
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
British military reports an explosion off the coast of Yemen in the key Bab el-Mandeb Strait
Chinese developer Evergrande risking liquidation if creditors veto its plan for handling huge debts
All the trading advice you’ve ever received boils down to this (Ad)
Breaches by Iran-affiliated hackers spanned multiple U.S. states, federal agencies say
Lacking counselors, US schools turn to the booming business of online therapy
All the trading advice you’ve ever received boils down to this (Ad)
Kiss say farewell to live touring, become first US band to go virtual and become digital avatars
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Man kills 4 relatives in Queens knife rampage, injures 2 officers before he's fatally shot by police
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
British military reports an explosion off the coast of Yemen in the key Bab el-Mandeb Strait
Chinese developer Evergrande risking liquidation if creditors veto its plan for handling huge debts
All the trading advice you’ve ever received boils down to this (Ad)
Breaches by Iran-affiliated hackers spanned multiple U.S. states, federal agencies say
Lacking counselors, US schools turn to the booming business of online therapy
All the trading advice you’ve ever received boils down to this (Ad)
Kiss say farewell to live touring, become first US band to go virtual and become digital avatars
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Man kills 4 relatives in Queens knife rampage, injures 2 officers before he's fatally shot by police
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
British military reports an explosion off the coast of Yemen in the key Bab el-Mandeb Strait
Chinese developer Evergrande risking liquidation if creditors veto its plan for handling huge debts
All the trading advice you’ve ever received boils down to this (Ad)
Breaches by Iran-affiliated hackers spanned multiple U.S. states, federal agencies say
Lacking counselors, US schools turn to the booming business of online therapy
All the trading advice you’ve ever received boils down to this (Ad)
Kiss say farewell to live touring, become first US band to go virtual and become digital avatars
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Man kills 4 relatives in Queens knife rampage, injures 2 officers before he's fatally shot by police
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
British military reports an explosion off the coast of Yemen in the key Bab el-Mandeb Strait
Chinese developer Evergrande risking liquidation if creditors veto its plan for handling huge debts
All the trading advice you’ve ever received boils down to this (Ad)
Breaches by Iran-affiliated hackers spanned multiple U.S. states, federal agencies say
Lacking counselors, US schools turn to the booming business of online therapy
All the trading advice you’ve ever received boils down to this (Ad)
Kiss say farewell to live touring, become first US band to go virtual and become digital avatars

KalVista Pharmaceuticals (KALV) ESG Score & Sustainability Data

$8.82
+0.38 (+4.50%)
(As of 12/1/2023 ET)
Compare
Today's Range
$8.51
$8.98
50-Day Range
$7.58
$10.08
52-Week Range
$5.00
$11.45
Volume
242,779 shs
Average Volume
272,034 shs
Market Capitalization
$303.41 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$19.50

Key ESG Takeaways for KalVista Pharmaceuticals

The key takeaways are AI-generated and highlight the main contributors behind the net impact scores of KalVista Pharmaceuticals. The insights are based on millions of scientific articles, along with the company-specific product and service portfolio.
  • Kalvista Pharmaceuticals seems to create the most significant positive value in categories , , and . The largest positive contribution comes from its impact, which is driven by its Preclinical research services for physical health and Clinical research services for physical health products.
  • Kalvista Pharmaceuticals uses resources or causes negative impacts mostly in categories , , and . The negative contribution in the impact category is driven by its Clinical research services for physical health and Preclinical research services for physical health products.
  • To improve its net impact, a company can either grow its positive impacts, or reduce its negative impacts. For example, by doubling its Preclinical research services for physical health business, Kalvista Pharmaceuticals would improve its net impact ratio by 1 percentage points.

KALV Impact Ratio

Net impact ratio represents the net impact of a company. It is defined as the (positive impacts - negative impacts) / positive impacts. The maximum value for net impact ratio is 100%, representing a theoretical company with no negative impacts. The minimum value is -∞. Net scores depend on the value sets that determine the importance of different impact categories.
+72.6%
The default value set, where each category is given the same weight.

Value Sets Value sets can be used to assess how different stakeholder values or emphasis on certain values might affect the net impact ratio.

Millennials
Value set of millennials (b. 1980 - 1999), based on Upright's annual Impact at Work survey.
+76.6%
Most Wanted Workforce
Value set of the most wanted workforce, based on Upright's annual Impact at Work survey.
+66.9%
Society First
Value set that emphasizes society impacts over other impacts.
+53.0%
Knowledge First
Value set that emphasizes knowledge impacts over other impacts.
+85.2%
Health First
Value set that emphasizes health impacts over other impacts.
+79.8%

KalVista Pharmaceuticals ESG Score + Net Impact Profile

ImpactNegativeScorePositive
+2.32
+2.32
+2.31
+2.31
+0.01
+0.01
-0.07
-0.07
+0.00
-0.01
+0.05
+0.06
0.00
+0.00
+2.40
+2.40
-0.00
0.00
+0.00
-1.72
-1.72
-0.40
+3.41
+3.81
-0.24
+0.04
+0.28
0.00
+0.00
-0.03
+0.02
+0.05
-0.05
+0.33
+0.37
-0.27
-0.27
+0.00
-0.02
-0.02
+0.00
-0.04
-0.04
+0.00
-0.05
-0.05
+0.00
-0.28
-0.28
+0.00

Upright Model Version 1.2.0
ESG Data Last Updated: September 27, 2023


About Upright's Net Impact Model

Upright's Net Impact Data quantifies the holistic value creation and impact of companies. It details both the negative and positive impacts a company has on the environment, health of people, society and knowledge, and forms a net sum of these costs and gains based on the economic costs of each impact category. The data is produced by Upright's Net Impact model, which is a mathematical model of the economy that produces continuously updated estimates of the net impact of companies by means of an information integration algorithm. The data is primarily sourced from the CORE open access database, which contains over 200 million scientific papers. Other sources of data include open databases published by the World Bank, IMF, WHO, OECD, IPCC, CDC and USDA.













KalVista Pharmaceuticals ESG Score - Frequently Asked Questions

How is KalVista Pharmaceuticals doing in terms of sustainability?

According to The Upright Project, which measures holistic value creation and impact of companies, KalVista Pharmaceuticals has a net impact ratio of 72.6%, indicating an overall positive sustainability impact. Kalvista Pharmaceuticals seems to create the most significant positive value in the categories of Physical diseases, Creating knowledge, and Jobs. Kalvista Pharmaceuticals uses resources or causes negative impacts mostly in the categories of Scarce human capital, Physical diseases, and Waste. Learn more on the sustainability of KalVista Pharmaceuticals.


More ESG Stocks and Research Tools

This page (NASDAQ:KALV) was last updated on 12/3/2023 by MarketBeat.com Staff

My Account -